Summary of Key Points Core Viewpoint - On October 30, 32 Hong Kong-listed companies conducted share buybacks, totaling 34.66 million shares and an aggregate amount of HKD 155 million [1][2]. Group 1: Buyback Details - China Feihe repurchased 12 million shares for HKD 50.23 million, with a highest price of HKD 4.200 and a lowest price of HKD 4.170, bringing its total buyback amount for the year to HKD 129 million [1][2]. - China Petroleum & Chemical Corporation repurchased 4.78 million shares for HKD 19.72 million, with a highest price of HKD 4.220 and a lowest price of HKD 4.100, accumulating a total buyback amount of HKD 794 million for the year [1][2]. - Stone Four Pharmaceutical Group repurchased 5 million shares for HKD 15.41 million, with a highest price of HKD 3.130 and a lowest price of HKD 3.030, totaling HKD 14.81 million in buybacks for the year [1][2]. Group 2: Buyback Rankings - The highest buyback amount on October 30 was from China Feihe at HKD 50.23 million, followed by China Petroleum & Chemical Corporation at HKD 19.72 million [1][2]. - In terms of share quantity, China Feihe led with 12 million shares repurchased, followed by Stone Four Pharmaceutical Group with 5 million shares and China Petroleum & Chemical Corporation with 4.78 million shares [1][2]. Group 3: Additional Buyback Information - Other notable companies involved in buybacks include Lianlian Digital and Guosheng Tang, with varying amounts and share quantities [1][2]. - The data also includes a detailed table of buybacks from various companies, highlighting their respective share counts, amounts, and price ranges [2][3].

Core Viewpoint - Daqin Railway Co., Ltd. has announced a share repurchase plan, intending to buy back shares worth between RMB 1 billion and 1.5 billion, with a maximum repurchase price set at RMB 8.19 per share, later adjusted to RMB 8.11 per share [2][3]. Group 1: Share Repurchase Basic Information - The company approved the share repurchase plan during board meetings held on August 27 and September 23, 2025, allowing the use of self-owned funds for the repurchase through the Shanghai Stock Exchange [2]. - The repurchased shares will be used for cancellation and reduction of the company's registered capital, with a repurchase period of 12 months from the approval date [2]. Group 2: Progress of Share Repurchase - As of October 30, 2025, the company has completed its first share repurchase, acquiring 866,500 shares, which represents 0.0043% of the total share capital of 20,147,177,716 shares [3]. - The highest and lowest prices for the repurchased shares were RMB 5.78 and RMB 5.75 per share, respectively, with a total expenditure of RMB 4,991,992 (excluding transaction fees) [3]. Group 3: Other Matters - The company will adhere to relevant regulations and make repurchase decisions based on market conditions, ensuring timely disclosure of information regarding the progress of the share repurchase [4].

Core Points - The company guarantees the authenticity, accuracy, and completeness of the quarterly report, with all board members and senior management assuming legal responsibility for its content [2][3]. Financial Data - The financial report for the third quarter is not audited [3]. - The company’s net capital and risk control indicators continue to comply with the relevant regulations set by the China Securities Regulatory Commission [4]. - Non-recurring gains and losses are applicable, with specific projects identified as significant [4]. Shareholder Information - There were no new litigation or arbitration cases involving amounts exceeding 50 million yuan during the reporting period [7]. - The company is involved in an ongoing appeal regarding a financing dispute with Southwest Synthetic Pharmaceutical Group, with the first-instance judgment requiring the company to receive over 178 million yuan in principal and interest [7]. Stock Issuance and Buyback - The company has received approval for a stock issuance to specific investors and will proceed according to legal requirements [8]. - The company completed a share buyback of 46,962,500 shares, representing 0.67% of the total share capital, at a total cost of approximately 300 million yuan [8]. Branch Changes - During the reporting period, the company did not establish new branches but relocated six securities business departments and closed seven [9].

Core Viewpoint - Meili Tianyuan Medical Health (02373) demonstrates strong confidence in its future development through share buybacks and insider purchases, indicating a belief that current share prices do not reflect the company's intrinsic value [1] Group 1: Insider Transactions - Non-executive director Ms. Yi Lin purchased a total of 61,000 shares in the open market using personal funds on October 24, 2025, reflecting a strong belief in the company's future prospects [1] Group 2: Share Buyback Activity - On October 30, 2025, the company repurchased 30,000 shares at a total transaction amount of approximately HKD 927,150, with an average price of about HKD 30.91 per share [1] - From October 15, 2025, to the date of the announcement, the company has repurchased a total of 475,000 shares for a total consideration of approximately HKD 15,069,220 [1] Group 3: Management's Perspective - The board believes that the current trading price of the shares does not reflect their intrinsic value and the actual business prospects of the company [1] - The board asserts that the share buyback reflects management's strong confidence in the long-term value of the enterprise, which is beneficial for enhancing the company's market value and shareholder return capabilities [1]

Group 1 - The company has approved a share repurchase plan to buy back between 30 million and 40 million shares within 12 months, with a total expenditure not exceeding 880 million RMB and a maximum price of 22 RMB per share [1] - The repurchased shares will be used for the company's equity incentive plan, and if the plan is not approved, the shares will be canceled within three years after the repurchase results are disclosed [1] - The company conducted its first share repurchase on October 30, 2025, buying back 1 million shares, which is 0.025% of the total share capital, at a total cost of approximately 16.15 million RMB [2] Group 2 - The company will adhere to relevant regulations and make repurchase decisions based on market conditions, ensuring timely information disclosure regarding the progress of the share repurchase [3]

Core Viewpoint - SF Holding (06936) has adjusted its A-share repurchase plan, increasing the total repurchase fund from a range of RMB 500 million to RMB 1 billion to a new range of RMB 1.5 billion to RMB 3 billion, with the implementation period extended to 12 months from the date of board approval [1] Group 1 - The total amount for the repurchase of shares has been increased to a minimum of RMB 1.5 billion and a maximum of RMB 3 billion [1] - The implementation period for the repurchase plan has been extended from April 28, 2025, to October 29, 2026 [1] - Other aspects of the A-share repurchase plan remain unchanged despite the adjustments [1]

Summary of Key Points Core Viewpoint - SF Holding (002352) has adjusted its share repurchase plan, increasing the total repurchase amount and extending the repurchase period [1] Group 1: Repurchase Plan Adjustments - The total amount for the first phase of A-share repurchase for 2025 has been raised from "not less than 500 million yuan and not more than 1 billion yuan" to "not less than 1.5 billion yuan and not more than 3 billion yuan" [1] - The repurchase period has been extended to October 29, 2026 [1] Group 2: Repurchase Progress - As of September 30, 2025, the company has repurchased 7,432,648 A-shares, amounting to approximately 299 million yuan, with an average transaction price of 40.36 yuan per share [1] - This repurchase represents about 0.15% of the total share capital [1] Group 3: Purpose of Repurchased Shares - The repurchased shares will be used for future A-share employee stock ownership plans or equity incentive plans [1] Group 4: Other Information - Other aspects of the repurchase plan remain unchanged, and the adjustments do not require a shareholder meeting for approval [1]

制度明确，公司回购股份适用于四类情形：一是减少公司注册资本；二是用于员工持股计划或股权激 励；三是转换公司发行的可转换为股票的公司债券；四是为维护公司价值及股东权益所必需。 登录新浪财经APP 搜索【信披】查看更多考评等级 近日，山东龙大美食股份有限公司（以下简称"龙大美食"）发布《股份回购管理制度》（以下简称"制 度"），旨在规范公司股份回购行为，维护股东特别是中小股东合法权益。该制度根据《公司法》《证 券法》等法律法规及公司章程制定，对回购股份的适用情形、条件、方式、资金来源、实施程序及信息 披露等作出全面规定。 明确回购适用情形及触发条件 实施期限与交易限制 回购期限根据情形不同有所区别：因减少注册资本、员工持股/股权激励、转换可转债情形回购的，期 限自相关决议通过之日起不超过十二个月；因维护公司价值情形回购的，期限不超过三个月。 以集中竞价交易方式回购时，公司不得在开盘集合竞价、收盘集合竞价及无涨跌幅限制交易日委托，且 委托价格不得为当日涨幅限制价格。此外，在重大事项决策至披露期间等特殊时段，公司不得实施回购 （维护价值且用于减资的情形除外）。 其中，第四类"维护公司价值及股东权益"需满足以下条件之一 ...

Core Viewpoint - On October 28, 32 Hong Kong-listed companies conducted share buybacks, totaling 13.81 million shares and an aggregate amount of HKD 75.40 million [1][2]. Summary by Category Buyback Activity - The company China Feihe repurchased 5.17 million shares for HKD 21.63 million, with a highest price of HKD 4.200 and a lowest price of HKD 4.110, bringing its total buyback amount for the year to HKD 78.70 million [1][2]. - Yum China repurchased 18,200 shares for HKD 6.29 million, with a highest price of HKD 347.600 and a lowest price of HKD 344.000, accumulating a total buyback amount of HKD 1.75 billion for the year [1][2]. - Linklogis Technology-W repurchased 1.46 million shares for HKD 4.76 million, with a highest price of HKD 3.260 and a lowest price of HKD 3.230, totaling HKD 248.10 million in buybacks for the year [1][2]. Top Buyback Companies - The highest buyback amount on October 28 was from China Feihe at HKD 21.63 million, followed by Yum China at HKD 6.29 million [1][2]. - In terms of share quantity, China Feihe also led with 5.17 million shares repurchased, followed by Shoujia Technology and Linklogis Technology-W with 1.55 million and 1.46 million shares, respectively [1][2].

Core Viewpoint - Zhejiang Guyue Longshan Shaoxing Wine Co., Ltd. has announced the progress of its share repurchase plan, indicating a commitment to enhancing shareholder value through strategic buybacks [2][3]. Group 1: Share Repurchase Basic Information - The company plans to repurchase shares using a budget of no less than RMB 200 million and no more than RMB 300 million, with a maximum purchase price of RMB 12.83 per share [2]. - The repurchased shares will be used for employee stock ownership plans or equity incentives [2]. Group 2: Progress of Share Repurchase - As of October 29, 2025, the company has repurchased 18.3521 million A-shares, representing 2.0133% of the total share capital [3]. - The highest purchase price was RMB 10.50 per share, while the lowest was RMB 9.48 per share, with a total expenditure of RMB 186.4041 million (excluding transaction fees) [3]. Group 3: Other Matters - The company will adhere to relevant regulations and make repurchase decisions based on market conditions, ensuring timely disclosure of progress to investors [4].